Mahmoud A. Rageh

Dr. Mahmoud A. Rageh

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
MRMahmoud A. Rageh
Mahmoud A. Rageh
MEMohamed El‐Khalawany
Mohamed El‐Khalawany
SIShady Mahmoud Attia Ibrahim
Shady Mahmoud Attia Ibrahim

28 November 2023 in Dermatologic Surgery
Verified
Journal Article
Closed access
MRMahmoud A. Rageh
Mahmoud A. Rageh
ATAbeer Attia Tawfik
Abeer Attia Tawfik
NANoha Abdallah
Noha Abdallah
SIShady Mahmoud Attia Ibrahim
Shady Mahmoud Attia Ibrahim
BACKGROUND: Atrophic acne scarring is a common problem. If left untreated, its implications can impair the quality of life. Various treatments, with differing degrees of success, are used to alleviate atrophic scars. OBJECTIVE: To assess the efficacy of nanofat versus platelet-rich plasma (PRP) as an adjuvant therapy to fractional CO2 laser (FCL) for atrophic acne scars. METHODS: This study included 35 patients with atrophic acne scars who received 3 sessions of FCL at 1-month intervals on both sides of the face, followed by intradermal PRP injection on the left side. A single session of nanofat was injected into the right side of the face 2 weeks before the laser sessions. The evaluation was conducted 3 months after the final treatment session. RESULTS: After treatment, the right side of the face showed a significant reduction in Goodman scores and the indentation index of the Antera camera. The left side showed a significant difference in Goodman scores, yet the Antera camera showed a nonsignificant improvement. Nonetheless, the difference between the 2 sides was statistically insignificant. CONCLUSION: Atrophic acne scars improved with both modalities. As a result, cotreatment with these techniques may synergistically affect atrophic acne scars in efficacy and safety.

4 February 2025 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
ATAbeer Attia Tawfik
Abeer Attia Tawfik
MRMahmoud A. Rageh
Mahmoud A. Rageh
Numerous techniques have been tried to treat acne scarring. Given its filling properties and the presence of adipose tissue-derived stem cells, autologous fat has been tried for treating acne scars in multiple studies, either alone or combined with other treatment approaches. This review focuses on autologous fat grafting in its different forms, including nanofat and stromal vascular fraction, as an efficient and safe modality for treating acne scars. PubMed, Embase, and Cochrane Library databases were used to search for relevant studies published from January 2017 to December 2022. We used a combination of the following keywords: “acne scar,” “acne scars,” “autologous fat transplantation,” “autologous fat grafting,” “fat grafting for acne scars,” “stromal vascular fraction,” “SVF,” and “nanofat.” Twelve studies were found utilizing autologous fat grafting in different forms, either used alone or combined with other treatment methods such as lasers and platelet-rich plasma for treating atrophic post-acne scars. Most studies showed that autologous fat grafting effectively treated acne scars with satisfying results.

1 March 2024 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
MRMahmoud A. Rageh
Mahmoud A. Rageh
SIShady Mahmoud Attia Ibrahim
Shady Mahmoud Attia Ibrahim
NANoha Abdallah
Noha Abdallah
ATAbeer Attia Tawfik
Abeer Attia Tawfik
Background: Atrophic acne scarring is a widely prevalent condition and one of the most distressing complications of acne vulgaris. Numerous options with variable outcomes are available for the treatment of acne scarring. Laser is considered a first‐line therapy for acne scars, and recently there has been a growing interest in using stem cells and their derivatives for treating acne scars. In addition, combined therapeutic modalities often achieve more satisfactory results than a single treatment. Objective: We tried to evaluate the role of nanofat and fractional CO2 laser as a combined treatment approach for atrophic acne scarring. Methods: Twenty-five patients with atrophic acne scarring were enrolled. They received a single session of intradermal nanofat injection, at different points 1 cm apart, for acne scars. Two weeks later, they were treated with three sessions of fractional CO2 laser at monthly intervals. Patients were evaluated three months after the last session using the quantitative Goodman and Baron scoring system. Pain, side effects, and patients’ satisfaction were also evaluated. Results: There were two males and 23 females with a mean age of 25.96 years. Their skin type ranged between Fitzpatrick skin type III, IV, and V. Boxcar scars were the most common scar type in 13 patients (52%). After treatment, there was a significant reduction (p < 0.05) in the quantitative Goodman and Baron scores. The improvement was more evident in rolling scars. Seven patients reported significant improvement, and 12 reported marked improvement. Conclusion: This study showed that combining nanofat and fractional CO2 laser is a safe and effective treatment modality for atrophic acne scars.

8 March 2023 in Dermatologic Surgery
Verified
Journal Article
Closed access
MHMohamed S. Hasan
Mohamed S. Hasan
AAAbdelraouf M. Almohsen
Abdelraouf M. Almohsen
MNMuhammad I. Nasr
Muhammad I. Nasr
MRMahmoud A. Rageh
Mahmoud A. Rageh
BACKGROUND: Autologous noncultured melanocyte–keratinocyte transplantation is one of the procedures used to treat stable vitiligo with varying reported results. Recipient site preparation is one of the variables that could affect repigmentation outcomes. OBJECTIVE: To assess the effectiveness of transplanting autologous melanocyte–keratinocyte suspension in patients with stable vitiligo and to compare recipient site preparation using dermabrasion versus microneedling. METHODS: From March 2020 to September 2022, this randomized comparative study included 40 patients with 40 stable vitiligo lesions managed by suspension transplants of melanocytes. Patients were divided into 2 groups: group A, where the recipient site was prepared using dermabrasion, and group B, which was done by microneedling. The assessment was performed 3 months after the treatment based on the degree of repigmentation (excellent, ≥90%; good, 50%–89%; fair, 20%–49%; and poor response, <20%). RESULTS: Both modalities resulted in effective repigmentation, but the dermabrasion group showed a statistically significant improvement and a satisfactory repigmentation rate. CONCLUSION: Autologous melanocyte transplantation is a safe and effective treatment method for stable vitiligo lesions that have not responded to other therapies. When compared with microneedling, dermabrasion produced better outcomes for recipient site preparation.

23 July 2022 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
MEMohamed El-Khalawany
Mohamed El-Khalawany
HHHussein M. M. Hassab-El-Naby
Hussein M. M. Hassab-El-Naby
AMAhmed Mustafa Mousa
Ahmed Mustafa Mousa
ASAhmed Sameh
Ahmed Sameh
MRMahmoud A. Rageh
Mahmoud A. Rageh
SASoha Aboeldahab
Soha Aboeldahab
Purpose: Basal cell carcinoma (BCC) is the most diagnosed type of cancer accounting for 80% of all keratinocyte malignancies. However, the exact demographic properties and clinicopathological criteria for BCC in Egyptians are not clearly reported. Our aim is to report and analyze the epidemiological and clinicopathological features of BCC in Egyptians. Methods: We retrospectively reviewed the medical records for patients diagnosed pathologically with BCC during the period from January 2017 to December 2021. Data were recruited from four dermatology centers with different geographical distributions. Results: We registered 544 patients. Their age ranged between 22–91 years with a mean of 61.6 ± 13.2 years. Females showed younger age of onset. The mean duration of the tumor was 3.9 ± 3.8 years. The most common involved region was the head (79.4%), and about one third of patients (32.2%) had a giant lesion (> 5 cm). The most common clinical presentation was ulcerative lesions (44.9%). Pathologically, the nodular type represented the most common variant (50.4%). Conclusion: Our results proposed that the annual incidence of BCC is increasing among Egyptians. Ultraviolet radiation is considered a high-risk factor of BCC leading to a higher affection of the head region and more prevalence in men. This study also highlights some criteria of BCC in Egyptians such as the long duration of the tumor, the early onset in females, the higher percentage of giant types, and the predominance of nodular type. To our knowledge, this is the first report describing the characteristic features of BCC among Egyptians.